Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 1 Absolute changes of von Willebrand factor levels over 48 h in patients receiving either enoxaparin, unfractionated heparin, PEG-hirudin, or dalteparin. Differences among treatment groups were analyzed by ANOVA and post hoc t tests with Bonferroni correction for multiple comparisons: after correction, comparisons were significant if p value was less than 0.0083. {Delta} von Willebrand factor was significantly lowered with PEG-hirudin and enoxaparin compared to unfractionated heparin.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement